This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sleator, E. K. Search for Related Content PubMed PubMed Citation Articles by Sleator, E. K. Social Bookmarking                         What's this?

Deleterious Effects of Drugs Used for Hyperactivity on Patients with Gilles de la Tourette Syndrome

Institute of Child Behavior and Development, University of Illinois, 51 Gerty Drive, Champaign, Illinois 61820

Two pediatricians failed to recognize Gilles de la Tourette syndrome in a child. The symptoms were exacerbated after the child took both pemoline and methylphenidate. All medications commonly used to treat hyperactivity may cause such exacerbation. Gilles de la Tourette syndrome is frequently asso ciated with symptoms characteristic of hyperactivity and often goes unrecog nized for long periods of time. The symptoms of the syndrome and the evidence that they are exacerbated by medication used to hyperactivity are briefly reviewed. Physicians should be aware of the possibility of Gilles de la Tourette syndrome in any hyperactive patient who manifests or has a history of a tic.

Clinical Pediatrics, Vol. 19, No. 7, 453-454 (1980)
DOI: 10.1177/000992288001900704


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. K. Ullmann and E. K. Sleator Responders, Nonresponders, and Placebo Responders Among Children with Attention Deficit Disorder: Importance of a Blinded Placebo Evaluation Clinical Pediatrics, December 1, 1986; 25(12): 594 - 599. [Abstract] [PDF]